Literature DB >> 3842629

Scintigraphy and contrast radiography for epiphora.

J D Rose, C B Clayton.   

Abstract

During a one-year period 53 patients were referred for the investigation of epiphora. All underwent bilateral dacryoscintigraphy. Following the isotope study the patients had either bilateral or unilateral macrodacryocystography; a total of 66 tear ducts were shown by this procedure. The scintigraphs were more sensitive for obstruction (51/66 systems or 77%) than radiography (33/66 systems or 51%). Normal dacryoscintigraphy was always associated with duct patency on dacryocystography. We have concluded that scintigraphy should always be the first investigation and that, if this is normal, radiography is not necessary. The use of digital subtraction imaging for the lacrimal passages is discussed. It is suggested that this may provide information obtained at present only by combining dacryoscintigraphy with conventional contrast radiography.

Entities:  

Mesh:

Year:  1985        PMID: 3842629     DOI: 10.1259/0007-1285-58-696-1183

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  4 in total

1.  Evaluation of Patients for Endoscopic DCR: Sac Syringing and Radionuclide Scintigraphy.

Authors:  Col Uma Patnaik; Maj Atul Gupta; Brig Ajith Nilakantan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-16

2.  Clinical value of dacryoscintigraphy using a simplified analysis.

Authors:  P L Jager; K Mansour; H Vrakkink-de Zoete; L Poot; J M M Hooijmans; K J Bruin; L J Blanksma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-18       Impact factor: 3.117

3.  Comparison of dacryocystography and lacrimal scintigraphy in the diagnosis of functional nasolacrimal duct obstruction.

Authors:  M J Wearne; J Pitts; J Frank; G E Rose
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

4.  Syringing has limited reliability in differentiating nasolacrimal duct stenosis from functional delay.

Authors:  Yinon Shapira; Valerie Juniat; Carmelo Macri; Dinesh Selva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-04-23       Impact factor: 3.535

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.